ARCHIVES

NCI Begins Large National Clinical Trial To Validate Biomarker For Lung Cancer

This article is from The Cancer Letter archive.

Vol. 31 No. 10 | October 31, 2008

Download PDF Visit The Full Archive

Related Articles

Massive New Radiation Research program Costing From $300-$400 Million Over 10 Years Suggested

February 11, 1977

ORI Final Findings Of Scientific Misconduct

September 16, 1994

First CCOP 3 Returns In; Payline Not Yet Determined; Goes to NCAB On Jan. 30

January 26, 1990

Breast-Conserving Procedures Lead To Frequent Follow-up Care

April 27, 2012

Analysis Reveals CAIX Subgroup Responsive to Rencarex Therapy

June 28, 2013

Docetaxel As Adjuvant Therapy Shows Benefit Over Standard

June 28, 2002